| Ytd | -91.58% | |
| 1y | -95.47% |
| Open | 0.35 | Prev Close | 0.37 | Low | 0.32 | High | 0.35 | Mkt Cap | 212.74K |
| Vol | 231.68K | Avg Vol | 6.66M | EPS | -20.89 | P/E | -0.02 | Forward P/E | N/A |
| Beta | 0.77 | Short Ratio | 6.03 | Inst. Own | 0.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.49 | 200-d Avg | 2.74 | 1yr Est | 0.00 |
Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's re
Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-mark
Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday&
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Eva Live gained 16.4% in pre-market trading after signing a letter of intent to acquire Airbeam Wire
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment
RUTHERFORD, N.J. and SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("
Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-
Transaction positions the combined company to execute a capital-efficient, repeatable strategy lever
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session
Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess
Shares of Aehr Test Systems (NASDAQ: AEHR) jumped 29.6% to $93.30 in pre-market trading. Aehr Test
Glucotrack Inc. shares jumped 69.27% after hours as investors reacted to the company's newly all
Glucotrack, Inc. (NASDAQ:GCTK) today announced the completion of its strategic business combination
Transaction positions the combined company to execute a capital-efficient, repeatable strategy lever
Gainers VYNE Therapeutics (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-m
Glucotrack, Inc. ("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical technolo
RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (“Glucotrack”, or the “Company”
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 66.9% to $6.31 during Thursda
RUTHERFORD, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or
Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administratio
Submission supports advancement of a long‑term, fully implantable, blood‑based continuous glucose mo
Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affir
RUTHERFORD, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” o
Seagate Technology Holdings (STX) shares rose 18% in pre-market trading after reporting strong Q3 re
RUTHERFORD, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” o
Bloom Energy (BE) rose in pre-market trading as it announces expanded partnership with Oracle (ORCL)
Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting
GlucoTrack, Inc. (NASDAQ: GCTK - Get Free Report) saw a large increase in short interest in the mont
GlucoTrack targets a Q2 2026 FDA IDE filing for CGM, backed by clinical data, manufacturing strategy